{"id":"W3004063334","doi":"10.1158/1078-0432.ccr-19-1945","title":"Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Academy of Finland; Mayo Clinic; Breast Cancer Research Foundation; Syöpäjärjestöt; Canadian Cancer Society","keywords":"Capecitabine; Medicine; Oncology; Internal medicine; Hazard ratio; Triple-negative breast cancer; Taxane; Breast cancer; Adjuvant; Proportional hazards model; Cancer; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002947037,0.0005690009,0.001108536,0.0001404015,0.0001961896,0.0006255708,0.0002670649,0.0004817143,0.002068052],"category_scores_gemma":[0.00227871,0.0001513245,0.0007751224,0.0001993015,0.0002734713,0.0003799689,0.0002179615,0.0007389322,0.0001601011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003693309,"about_ca_system_score_gemma":0.0004149355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002380251,"about_ca_topic_score_gemma":0.0005200536,"domain_scores_codex":[0.9993197,0.0004234214,0.00003384685,0.0001181903,0.00005763339,0.00004721306],"domain_scores_gemma":[0.9988206,0.0005482762,0.0003354263,0.00007680163,0.0000585549,0.0001602767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8287627,0.001193571,0.1135784,0.0008413156,0.002965329,0.0001441752,0.00006546604,0.001728691,0.007592873,0.0002286853,0.002047666,0.04085122],"study_design_scores_gemma":[0.1939366,0.1089883,0.6580685,0.0004292541,0.01098194,0.0009972625,0.0001593861,0.008051627,0.008193567,0.001716438,0.008369521,0.0001076035],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994619,0.003228431,0.0002883808,0.0001995324,0.0000619269,0.0001618026,0.0004827232,0.00001506607,0.0009432088],"genre_scores_gemma":[0.9976484,0.0003439939,0.0003178342,0.0001659589,0.00005482224,0.0001544774,0.0008343986,0.000002759704,0.0004773956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002947037,"threshold_uncertainty_score":0.0155856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2039480375743586,"score_gpt":0.5027236238608903,"score_spread":0.2987755862865317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}